Rivaroxaban May Lead to Higher GI Bleeding Risk Than Other DOACs
Rivaroxaban was associated with an increased risk of overall and major gastrointestinal bleeding, compared with apixaban or dabigatran, a study shows.
Donc Rockey Neenas Abraham Arnar Bragi Ingason Landspitali University Hospital University Of South Carolina University Hospital Research Fund
Source: medscape.com